Mujin Fang
State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Development of COVID-19 Vaccine Candidates Using Attenuated Recombinant Vesicular Stomatitis Virus Vectors with M Protein Mutations.
Journal: Viruses
Published: May 23, 2025
VP8 Mosaic Nanoparticles Elicit Cross-Neutralizing Immune Responses and Provide Protection Against Heterotypic Rotavirus Challenge in Mice.
Journal: ACS nano
Published: November 05, 2024
Transgenic mice expressing the human CDHR3 receptor: A sensitive RV-C infection model for the evaluation of vaccines and therapeutics.
Journal: Antiviral research
Published: October 27, 2024
Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia.
Journal: Signal transduction and targeted therapy
Published: October 19, 2024
Construction of a Vero cell line expression human KREMEN1 for the development of CVA6 vaccines.
Journal: Virology journal
Published: October 08, 2024
Constructing coral reef-like imprinted structure on molecularly imprinted nanocomposite membranes based on nanospheres with hydrophilic multicores for selective separation of acteoside.
Journal: Journal of chromatography. A
Published: August 27, 2024
Substantial spillover burden of rat hepatitis E virus in humans.
Journal: Nature communications
Published: July 22, 2024
Enhancing Tumor Immunity with IL-12 and PD-1 Blockade: A Strategy for Inducing Robust Central Memory T Cell Responses in Resistant Cancer Model.
Journal: Antibodies (Basel, Switzerland)
Published: June 11, 2024
Author Correction: Design of a recombinant asparaginyl ligase for site-specific modification using efficient recognition and nucleophile motifs.
Journal: Communications chemistry
Published: June 03, 2024
Last Updated: 09/26/2026